qwertyuiopasdfghjklzxcvbnmqwerty

uiopasdfghjklzxcvbnmqwertyuiopasd
fghjklzxcvbnmqwertyuiopasdfghjklzx
cvbnmqwertyuiopasdfghjklzxcvbnmq
wertyuiopasdfghjklzxcvbnmqwertyui
opasdfghjklzxcvbnmqwertyuiopasdfg
hjklzxcvbnmqwertyuiopasdfghjklzxc
vbnmqwertyuiopasdfghjklzxcvbnmq
wertyuiopasdfghjklzxcvbnmqwertyui
opasdfghjklzxcvbnmqwertyuiopasdfg
NIFTY OUTLOOK
hjklzxcvbnmqwertyuiopasdfghjklzxc
REPORT
vbnmqwertyuiopasdfghjklzxcvbnmq
th
18 Sep 2017
wertyuiopasdfghjklzxcvbnmqwertyui
opasdfghjklzxcvbnmqwertyuiopasdfg
hjklzxcvbnmrtyuiopasdfghjklzxcvbn
mqwertyuiopasdfghjklzxcvbnmqwert
yuiopasdfghjklzxcvbnmqwertyuiopas
 18th Sep 2017

NIFTY

NIFTY FUT : R1:10135 R2:10167 R3:10190

PIVOT : 10099 S1:10067 S2:10029 S3:10000

NIFTY DAILY CHART

NIFTY OUTLOOK
Nifty is likely to open with a gap up opening. Momentum indicators are indicating towards a bulls rule ahead in
this week. Global market is indicating towards a bullish rally for the Indian market too. Positional traders are
advice to average their longs on every -50 pts dips on nifty while for shorts it is strictly advised to use stop loss at
10175.Intraday traders are advised to adopt buy on dips strategy for today.

Strategy: Long Nifty fut around 10150 t1 10200 sl 10110

Name Current Value Change % Chg Open High Low

FTSE 100 (Sep
15) 7,215.47 -79.92 -1.11 7,295.39 7,295.39 7,196.58
CAC 40 (Sep 15) 5,213.91 -11.29 -0.22 5,220.89 5,237.17 5,201.97
DAX (Sep 15) 12,518.81 -21.64 -0.17 12,525.36 12,561.35 12,506.94
Nikkei 225 (Sep
15) 19,909.50 102.06 0.51 19,793.80 19,933.40 19,787.65
Straits Times
(Sep 18) 3,244.22 34.66 1.07 3,230.38 3,246.49 3,225.48
Hang Seng (Sep
18) 28,108.50 300.91 1.07 27,971.37 28,113.96 27,917.18
Taiwan
Weighted (Sep
18) 10,627.29 46.88 0.44 10,590.80 10,634.53 10,581.81
SGX Nifty (Sep
18) 10,152.00 58 0.57 10,099.00 10,153.50 10,087.50

WWW.EQUITYRESEARCHLAB.COM
 18th Sep 2017

CORPORATE NEWS

-Listings today - Bharat Road Network, Dixon Technologies

-Tata Motors' compact SUV offering Nexon will be launched on September 21
-Dr Reddy's Labs intimated exchanges about audit of API Mirfield plant, United Kingdom, by the US FDA
-Mahanagar Gas starts piped natural gas (PNG) supply in Dombivaili (East) area of Maharashtra
-Laurus Labs receives the EIR from USFDA, and also successfully completes the German Regulatory Authority
for Unit 2 and WHO inspections for Units 1 & 3
-Balrampur Chini starts NBFC to invest in financing activities in the education sector
-Govt told steel firms to keep process below Rs 40,000 per tonne: BS
-Government may raise Rs 15,000 crore from IPO of New India Insurance and GIC Re: BS
-Fosun Group to buy 74 percent stake in Gland Pharma for USD 1.1 billion: Mint
-Hardcastle, Jubilant, Speciality, Moon Beverages, Lite Bite keen to partner McDonald's: ET
-Stakeholders Empowerment Services (SES) urges Bharti shareholders to reject Telenor deal: ET
-HDFC Life IPO may be pushed to Q3: ToI
-ITC looking to expand by 40 new hotels with 5000 rooms in pipeline: Mint
-TVS eyes electric two wheeler space, to roll out products soon: ET
-Institutional investors in PTC India seek board representation: ET
-Tata Sons seeks shareholders' nod to amend voting rights: ET
-Cognizant draws plan to strike 5-10 deals per year
-Government to sell Air India Properties owned by them: ET
-BPCL eyes government stake in GAIL India for Rs18,000-20,000 crore: Mint
-Cadila: Zydus' Nesher Pharma gets US FDA final nod for Oseltamivir powder-Axis Bank keeps its MCLR
unchanged

WWW.EQUITYRESEARCHLAB.COM
 18th Sep 2017

ERL RESEARCH TEAM

Member Name Designation

Mr. Tuhinanshu Jain Research Head
Mr. Manish Bimal Sr. Research Analyst
Mr. Anand Sharma Research Analyst
Mr. Sumit Sahu Research Analyst

DISCLAIMER

The information and views in this report, our website & all the service we provide are believed to be
reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have
the right to choose the product/s that suits them the most. Investment in Stocks has its own risks.
Sincere efforts have been made to present the right investment perspective. The information contained
herein is based on analysis and up on sources that we consider reliable. We, however, do not vouch
for the accuracy or the completeness thereof. This material is for personal information and we are not
responsible for any loss incurred based upon it & takes no responsibility whatsoever for any financial
profit s or loss which may arise from the recommendations above. The stock price projections shown
are not necessarily indicative of future price performance. The information herein, together with all
estimates and forecasts, can change without notice.

Equity Research Lab does not purport to be an invitation or an offer to buy or sell any financial
instrument. Analyst or any person related to Equity Research Lab might be holding positions in the
stocks recommended. It is understood that anyone who is browsing through the site has done so at his
free will and does not read any views expressed as a recommendation for which either the site or its
owners or anyone can be held responsible for. Any surfing and reading of the information is the
acceptance of this disclaimer.

Our Clients (Paid or Unpaid), any third party or anyone else have no rights to forward or share our
calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly
or indirectly by them. If found so then Serious Legal Actions can be taken. Any surfing and reading of
the information is the acceptance of this disclaimer.

ALL RIGHTS RESERVED.

WWW.EQUITYRESEARCHLAB.COM